Episode 29: A Hong Kong heat-check, a $20 million wrist slap, and pharma's (other) diversity problem
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Is a biotech bubble inflating in China? Do the feds coddle CEOs? And why don't clinical trials look like America?